Publication:
The protective effect of melatonin on cisplatin nephrotoxicity

dc.contributor.authorsSener, G; Satiroglu, H; Kabasakal, L; Arbak, S; Oner, S; Ercan, F; Keyer-Uysal, M
dc.date.accessioned2022-03-12T16:59:32Z
dc.date.accessioned2026-01-10T16:53:31Z
dc.date.available2022-03-12T16:59:32Z
dc.date.issued2000
dc.description.abstractRegarding the mechanisms of cisplatin (CP) nephrotoxicity, several hypotheses have been put forward, among which oxidative stress (including depiction of glutathione and production of lipid peroxide) is noticeable. This investigation elucidates the role of the antioxidant system in CP-induced nephrotoxieity and the nc phroprotection by melatonin. Balb/c mice were injected i.p. with: 1) vehicle control; 2) a single dose of 6.5 mg/kg cisplatin, CP group; 3) melatonin in a dose of 10 mg/kg for 5 days after CP injection, CP-M group; 4) melatonin (10 mg/kg) for 5 days before and after CP injection, M-CP-M group; 5) melatonin in a dose of 10 mg:kg For 5 days, M group. Mice were sacrificed 5 days after CP injection to determine blood urea nitrogen (BUN) and serum creatinine, Renal lipid peroxidation (LF) and glutathione (GSH) levels were evaluated in kidney homogenates. Cisplatin administration resulted in increased LP, BUN and serum creatinine levels and decreased GSH levels, whereas melatonin reversed these effects. Morphological kidney damage was apparent in the CP group. Mentioned degeneration was moderate in the CP-M group, whereas morphological findings of the M-CP-M group implied a well preserved kidney tissue. When M was administered alone, it didn't cause any significant change in biochemical parameters. Both C and M groups exhibited similar biochemical and morphological findings in light and transmission electron microscope observation. In conclusion, the present study suggests that melatonin may be of therapeutic benefit when used with CP. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
dc.identifier.doidoiWOS:000166516000004
dc.identifier.issn0767-3981
dc.identifier.pubmed11206705
dc.identifier.urihttps://hdl.handle.net/11424/227207
dc.identifier.wosWOS:000166516000004
dc.language.isoeng
dc.publisherEDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
dc.relation.ispartofFUNDAMENTAL & CLINICAL PHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectcisplatin
dc.subjectmelatonin
dc.subjectnephrotoxicity
dc.subjectlipid peroxidation
dc.subjectglutathione
dc.subjectINDUCED LIPID-PEROXIDATION
dc.subjectCIS-PLATINUM NEPHROTOXICITY
dc.subjectRENAL CORTICAL SLICES
dc.subjectRAT-KIDNEY
dc.subjectGLUTATHIONE
dc.subjectANTIOXIDANT
dc.subjectDAMAGE
dc.subjectDRUG
dc.subjectMECHANISM
dc.subjectPREVENTS
dc.titleThe protective effect of melatonin on cisplatin nephrotoxicity
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage560
oaire.citation.issue6
oaire.citation.startPage553
oaire.citation.titleFUNDAMENTAL & CLINICAL PHARMACOLOGY
oaire.citation.volume14

Files